Lipocine Inc (LPCN): Congress and insider trades
Who in Congress and inside the company traded LPCN, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Lipocine Inc (LPCN) is a listed stock on NASDAQ.
- Insiders filed 4 open market buys worth $435K and 0 sells worth $0, the latest filed 2026-04-07 (7 April 2026).
- Across 4 scored buys, Insiders averaged +8.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in LPCN
as of 2026-04-07| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 7 Apr 2026 | Higuchi John W. | buy | 40,000 | $2.03 | $81.2K | +5.1% |
| 6 Apr 2026 | Higuchi John W. | buy | 123,000 | $2.05 | $252K | +9.2% |
| 6 Apr 2026 | Patel Mahesh V. | buy | 25,000 | $2.03 | $50.8K | +9.2% |
| 2 Apr 2026 | Patel Mahesh V. | buy | 25,000 | $2.02 | $50.5K | +9.9% |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought LPCN?
0 Congress buys by 0 members and 4 insider buys are on file. The tables on this page list every one.
Did buying LPCN after a disclosure beat the market?
Across 4 scored buys, Insiders averaged +8.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.